AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 178 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,383,000 | +13.1% | 359,863 | -8.0% | 0.00% | 0.0% |
| Q2 2020 | $2,992,000 | +21.8% | 391,129 | -1.6% | 0.00% | 0.0% |
| Q1 2020 | $2,456,000 | -52.2% | 397,545 | -5.8% | 0.00% | 0.0% |
| Q4 2019 | $5,136,000 | +6.4% | 422,085 | +1.0% | 0.00% | 0.0% |
| Q3 2019 | $4,828,000 | +14.0% | 418,027 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $4,235,000 | -20.2% | 423,924 | +2.9% | 0.00% | 0.0% |
| Q1 2019 | $5,305,000 | -16.3% | 411,861 | -1.3% | 0.00% | -50.0% |
| Q4 2018 | $6,341,000 | -24.4% | 417,358 | -0.4% | 0.00% | 0.0% |
| Q3 2018 | $8,385,000 | +5.4% | 419,221 | +2.7% | 0.00% | 0.0% |
| Q2 2018 | $7,958,000 | -6.2% | 408,045 | -3.1% | 0.00% | 0.0% |
| Q1 2018 | $8,482,000 | +0.4% | 420,925 | -34.0% | 0.00% | 0.0% |
| Q4 2017 | $8,450,000 | -35.4% | 637,748 | -10.1% | 0.00% | -50.0% |
| Q3 2017 | $13,084,000 | -0.9% | 709,139 | -1.1% | 0.00% | 0.0% |
| Q2 2017 | $13,197,000 | -19.3% | 717,253 | -1.1% | 0.00% | -20.0% |
| Q1 2017 | $16,353,000 | +4.9% | 725,197 | +61.8% | 0.01% | +25.0% |
| Q4 2016 | $15,595,000 | +35.1% | 448,145 | -4.8% | 0.00% | +33.3% |
| Q3 2016 | $11,542,000 | -1.2% | 470,915 | -3.5% | 0.00% | -25.0% |
| Q2 2016 | $11,677,000 | +2.3% | 488,181 | +0.1% | 0.00% | +33.3% |
| Q1 2016 | $11,413,000 | +54.6% | 487,721 | +99.4% | 0.00% | +50.0% |
| Q4 2015 | $7,382,000 | -1.2% | 244,535 | +30.0% | 0.00% | 0.0% |
| Q3 2015 | $7,472,000 | -40.0% | 188,084 | +4.3% | 0.00% | -33.3% |
| Q2 2015 | $12,449,000 | +50.8% | 180,273 | +19.4% | 0.00% | +50.0% |
| Q1 2015 | $8,254,000 | +39.3% | 151,017 | +8.6% | 0.00% | 0.0% |
| Q4 2014 | $5,925,000 | +15.8% | 139,017 | -13.3% | 0.00% | +100.0% |
| Q3 2014 | $5,118,000 | +6.4% | 160,375 | -30.9% | 0.00% | 0.0% |
| Q2 2014 | $4,810,000 | +107.8% | 232,112 | +94.0% | 0.00% | 0.0% |
| Q1 2014 | $2,315,000 | -21.5% | 119,650 | -1.4% | 0.00% | 0.0% |
| Q4 2013 | $2,948,000 | -42.2% | 121,388 | -48.9% | 0.00% | 0.0% |
| Q3 2013 | $5,104,000 | +97.2% | 237,664 | +104.4% | 0.00% | 0.0% |
| Q2 2013 | $2,588,000 | – | 116,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
| Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
| Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
| March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
| Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
| AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
| CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
| Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |